Rare diseases
Investigational molecules
Locations
Via Michele Barozzi 2, 20122 Milan, Italy
Napo Therapeutics S.p.A. focuses its clinical research on Short Bowel Syndrome with Intestinal Failure, particularly in adults living without colon-in-continuity. This area reflects a concentrated interest in severe intestinal malabsorption and related digestive complications.
The sponsor’s work in this field addresses complex gastrointestinal conditions where restoration of fluid balance, nutrient absorption, and bowel function is clinically important.
Napo Therapeutics S.p.A. runs clinical trials in conditions such as Short-bowel syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
